FDA Investigator Sarah E Morris
Sarah E Morris has conducted inspections on 54 sites in 1 countries as of 11 Apr 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
54
Last Inspection Date:
11 Apr 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Sarah E Morris:
Adree N Anderson,
Alan M Barker,
Alysia C Alger,
Andrew K Schaal,
Ashlee M Ward,
Ashley A Mutawakkil,
Barbara I Rogolsky,
Brenda C Hamilton,
Brent T Hall,
Brett R Havranek,
Bruce E Taylor,
Carmen Y Fisher,
Catherine R Olguin,
Cody D Rickman,
Cynthia M Goudeau,
Danial S Hutchison,
Darrah,
David F Graham,
Dawn C Olenjack,
Dina K West,
Dwight D Ferguson,
Eric C Fox,
Eric C Nielsen,
Eric M Mueller, PharmD,
Erika V Butler,
Erin C Dugan,
Farhana Khan,
Gwyn G Dickinson,
Heath W Cartwright,
James D Planchon,
Jeffery A Hangartner,
Jeffrey B Moody,
Jennifer Cahill,
Jessica E Hensley,
Jessica L Peterson,
Johnson,
Jonathan R Campos,
Joseph R Lambert,
Julie N Vosilus,
Kara L Roden,
Karen C Daugherty,
Katherine M Taylor,
Kathleen B Swat,
Kathleen J Close,
Kellia N Hicks,
Kimberlee A Ewing,
Kristi B Panzer,
LCDR Audra J Lenhart,
LCDR Matthew J Morrison,
LCDR Matthew R Mcnew, MPH, REHS/RS,
Linhart,
Lisa L Gilliam,
Lori A Gioia,
Louis S Chen,
Mathur,
Matthew R Sleeter,
Melinda L Rice,
Michael A Feingold,
Michele L Obert,
Michele Perry Williams,
Miranda D Mcdonald,
Monique M Brooks,
Nadine Nanko Johnson,
Naseem S Jouhari,
Nia K Walker,
Nicole C Mayfield,
Patrick L Wisor,
Richard D Coleman,
Richard L Rutherford,
Robert J Ham,
Robert R Wilson,
Samuel K Gibbons, Jr,
Shafiq S Ahadi,
Shanna R Haden,
Sharon K Thoma, PharmD,
Sheri L Stephenson,
Shirley J Berryman,
Steven P Allen,
Stroman,
Susan M Von Drasek,
Tamara J Umscheid,
Tara L Greene,
Teresa S Johnson,
Tristian E Strait,
Verlinda A Narcisse,
Vickie J Kanion,
Victoria A Wagoner,
Walsworth,
Warren J Lopicka,
Wayne D Mcgrath,
Weston K Szymanski,
William C Corley,
William F Lagud, Jr,
Zachary A Bogorad
Sarah E Morris's Documents
Publish Date | Document Type | Title |
---|---|---|
September, 2009 | FDA 483 | Cardiovascular Imaging Technologies, LLC. - Form 483, 2009-09-08 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more